Aptamer Group (APTA) Competitors GBX 0.34 +0.05 (+17.24%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors APTA vs. OBI, HEMO, AOR, RLM, NSCI, OPTI, ONC, SNG, BVX, and CIZShould you be buying Aptamer Group stock or one of its competitors? The main competitors of Aptamer Group include Ondine Biomedical (OBI), Hemogenyx Pharmaceuticals (HEMO), AorTech International (AOR), Realm Therapeutics (RLM), NetScientific (NSCI), OptiBiotix Health (OPTI), Oncimmune (ONC), Synairgen (SNG), BiVictriX Therapeutics (BVX), and Cizzle Biotechnology (CIZ). These companies are all part of the "biotechnology" industry. Aptamer Group vs. Ondine Biomedical Hemogenyx Pharmaceuticals AorTech International Realm Therapeutics NetScientific OptiBiotix Health Oncimmune Synairgen BiVictriX Therapeutics Cizzle Biotechnology Ondine Biomedical (LON:OBI) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, community ranking, profitability, media sentiment, valuation and analyst recommendations. Which has more volatility & risk, OBI or APTA? Ondine Biomedical has a beta of 0.1, meaning that its share price is 90% less volatile than the S&P 500. Comparatively, Aptamer Group has a beta of -0.52, meaning that its share price is 152% less volatile than the S&P 500. Which has better earnings & valuation, OBI or APTA? Aptamer Group has lower revenue, but higher earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOndine Biomedical£1.63M14.03-£14.27M-£0.03-275.00Aptamer Group£1.03M6.34-£7.01M-£0.08-4.25 Do insiders and institutionals believe in OBI or APTA? 20.6% of Ondine Biomedical shares are held by institutional investors. Comparatively, 11.7% of Aptamer Group shares are held by institutional investors. 36.7% of Ondine Biomedical shares are held by insiders. Comparatively, 13.2% of Aptamer Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is OBI or APTA more profitable? Aptamer Group's return on equity of -187.53% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Ondine BiomedicalN/A -685.59% -159.71% Aptamer Group N/A -187.53%-44.96% Does the media prefer OBI or APTA? In the previous week, Ondine Biomedical's average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score. Company Overall Sentiment Ondine Biomedical Neutral Aptamer Group Neutral Does the MarketBeat Community favor OBI or APTA? Ondine Biomedical received 1 more outperform votes than Aptamer Group when rated by MarketBeat users. CompanyUnderperformOutperformOndine BiomedicalOutperform Votes1100.00% Underperform VotesNo VotesAptamer GroupN/AN/A SummaryOndine Biomedical beats Aptamer Group on 7 of the 11 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Aptamer Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APTA vs. The Competition Export to ExcelMetricAptamer GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£6.53M£144.59M£5.17B£1.43BDividend YieldN/A3.56%5.05%11.87%P/E Ratio-4.25186.84116.121,567.77Price / Sales6.3415,975.521,244.07213,480.60Price / CashN/A11.7239.8033.61Price / Book0.347.257.052.85Net Income-£7.01M-£18.73M£118.73M£154.74M7 Day Performance19.30%0.10%2.15%4.50%1 Month Performance55.25%7.34%-3.06%4.10%1 Year Performance-70.43%27.85%33.51%95.17% Aptamer Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTAAptamer GroupN/AGBX 0.34+17.2%N/A-82.6%£6.53M£1.03M-4.2537High Trading VolumeOBIOndine BiomedicalN/AGBX 8.13flatN/A-14.5%£22.53M£1.63M-270.83N/AHEMOHemogenyx PharmaceuticalsN/AGBX 1.53+6.3%N/A-38.3%£20.44MN/A-155.0014News CoverageGap UpAORAorTech InternationalN/AGBX 123.50-2.4%N/A+0.0%£19.99M£539,000.00-33.383RLMRealm TherapeuticsN/AGBX 11.50flatN/A+0.0%£13.41M£501,919.00-0.66N/ANSCINetScientificN/AN/AN/AN/A£12.81M£1.45M-486.3626OPTIOptiBiotix HealthN/AGBX 12.25-5.8%N/A-55.5%£12.00M£1.26M-404.071Gap DownONCOncimmuneN/AGBX 15.15+0.3%N/A-32.4%£11.23M£1.21M-504.6752Positive NewsSNGSynairgenN/AGBX 4.63+0.9%N/A-23.1%£9.32M£79,000.00-146.6034Gap UpBVXBiVictriX TherapeuticsN/AN/AN/A-9.1%£8.25MN/A-250.0017Gap UpHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 1.90+11.8%N/A-9.5%£7.53M£25,000.00-183.004Gap Up Related Companies and Tools Related Companies Ondine Biomedical Alternatives Hemogenyx Pharmaceuticals Alternatives AorTech International Alternatives Realm Therapeutics Alternatives NetScientific Alternatives OptiBiotix Health Alternatives Oncimmune Alternatives Synairgen Alternatives BiVictriX Therapeutics Alternatives Cizzle Biotechnology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:APTA) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored25X predicted for “Amazon Coin” – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptamer Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptamer Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APTA Stock Alerts